^
Association details:
| Biomarker: | VEGFA 1154G/A |
|---|---|
| Cancer: | Diffuse Large B Cell Lymphoma |
| Regimen: | R-CHOP (cyclophosphamide + doxorubicin hydrochloride + + Rituxan (rituximab) + vincristine) |
| Direction: | Resistant |
Evidence:
Source:
Title:
Angiogenesis' related genetic variants alter clinical features and prognosis of diffuse large B-cell lymphoma patients
Published date:
06/17/2021
Excerpt:
Patients were homogeneously treated with R-CHOP...shorter event-free and overall survival were seen in patients with VEGFA -1154GA or AA genotype and VEGFA ATAGCC haplotype.
DOI:
10.3233/TUB-211510
